Cite
HARVARD Citation
Chen, R. et al. (2020). HMGB1 as a potential biomarker and therapeutic target for severe COVID-19. Heliyon. 6 (12), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chen, R. et al. (2020). HMGB1 as a potential biomarker and therapeutic target for severe COVID-19. Heliyon. 6 (12), p. . [Online].